Polymer-free Amphilimus (Sirolimus + organic acid) eluting coronary stent. The absence of the polymer minimizes the risk of inflammation/thrombosis, while the propriety formulation enhances drug absorption. Product Advantages Abluminal Reservoir Technology Controlled and directed drug elution as a result of the Abluminal Reservoir Technology Amphilimus™ Formulation Optimal efficacy achieved through an homogeneous drug distribution and improved bioavailability due to the proprietary Amphilimus™ formulation, which is the combination of Sirolimus and an organic acid Bio Inducer Surface Proven bio and haemo-compatibility enabled by the Bio Inducer Surface coating, which accelerates the rate of endothelization and reduces thrombogenicity Coronary stent - Polymer-free drug release device - Stent material: L605 Cobalt Chromium alloy - Abluminal reservoirs for drug loading - Strut surface coating: Bio Inducer Surface (Carbofilm) - Strut thickness: 70 – 80?m - 2 radiopaque platinum markers at stent ends - No stent foreshortening during expansion Drug releasing formulation - Amphilimus formulation: Sirolimus + organic acid Device specifications - Guiding catheter compatibility: 5F (0.058”) - Guidewire compatibility: 0.014” - Nominal Pressure (NP): 9 ATM - Rated Burst Pressure (RBP): 18 ATM - Average Burst Pressure (ABP): 24 ATM